Back
Novo Nordisk AS Stock Price Chart
Sponsored
NVO
Sponsored
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
NVO
Novo Nordisk AS
Last Price:
110.28
Seasonality Move:
8.52%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and NVO is experiencing slight buying pressure.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.66 | Buy |
20-day SMA: | 105.89 | Buy |
50-day SMA: | 112.85 | Sell |
200-day SMA: | 127.46 | Sell |
8-day EMA: | 106.18 | Buy |
20-day EMA: | 107.07 | Buy |
50-day EMA: | 112.92 | Sell |
200-day EMA: | 119.81 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.08 | Sell |
Relative Strength Index (14 RSI): | 50.71 | Buy |
Chaikin Money Flow: | 219863 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.69 - 110.65) | Buy |
Bollinger Bands (100): | (111.42 - 134.62) | Sell |
Novo Nordisk AS Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
- Novo Nordisk AS share price is 108.67 while NVO 8-day simple moving average is 105.66, which is a Buy signal.
- The stock price of NVO is 108.67 while Novo Nordisk AS 20-day SMA is 105.89, which makes it a Buy.
- Novo Nordisk AS 50-day simple moving average is 112.85 while NVO share price is 108.67, making it a Sell technically.
- NVO stock price is 108.67 and Novo Nordisk AS 200-day simple moving average is 127.46, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
48
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a Sell
The current Novo Nordisk AS [NVO] share price is $108.67. The Score for NVO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
482.8B
Price in USD:
108.67
Share Volume:
4.35M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
94.73
Sell
48
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?
The Novo Nordisk AS stock price is 108.67 USD today. -
Will NVO stock go up or go down?
Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators -
Is Novo Nordisk AS overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
- Novo Nordisk AS share price is 108.67 while NVO 8-day exponential moving average is 106.18, which is a Buy signal.
- The stock price of NVO is 108.67 while Novo Nordisk AS 20-day EMA is 107.07, which makes it a Buy.
- Novo Nordisk AS 50-day exponential moving average is 112.92 while NVO share price is 108.67, making it a Sell technically.
- NVO stock price is 108.67 and Novo Nordisk AS 200-day simple moving average is 119.81, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.73 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
- NVO Moving Average Covergence Divergence (MACD) indicator is -2.08, suggesting Novo Nordisk AS is a Sell
- Novo Nordisk AS Relative Strength Index (RSI) is 50.71, which suggest Novo Nordisk AS is overbought
- The Bollinger Bands (25) for Novo Nordisk AS is (103.69 - 110.65), which suggest Novo Nordisk AS is a Sell
- The Bollinger Bands (100) for Novo Nordisk AS is (111.42 - 134.62), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.